301 related articles for article (PubMed ID: 18537577)
1. Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions.
Urichuk L; Prior TI; Dursun S; Baker G
Curr Drug Metab; 2008 Jun; 9(5):410-8. PubMed ID: 18537577
[TBL] [Abstract][Full Text] [Related]
2. Interactions between the cytochrome P450 system and the second-generation antipsychotics.
Prior TI; Baker GB
J Psychiatry Neurosci; 2003 Mar; 28(2):99-112. PubMed ID: 12670127
[TBL] [Abstract][Full Text] [Related]
3. Drug metabolism and atypical antipsychotics.
Prior TI; Chue PS; Tibbo P; Baker GB
Eur Neuropsychopharmacol; 1999 Jun; 9(4):301-9. PubMed ID: 10422890
[TBL] [Abstract][Full Text] [Related]
4. Metabolic drug interactions with newer antipsychotics: a comparative review.
Spina E; de Leon J
Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):4-22. PubMed ID: 17214606
[TBL] [Abstract][Full Text] [Related]
5. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452
[TBL] [Abstract][Full Text] [Related]
6. Metabolic drug interactions with new psychotropic agents.
Spina E; Scordo MG; D'Arrigo C
Fundam Clin Pharmacol; 2003 Oct; 17(5):517-38. PubMed ID: 14703714
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine.
Fang J; Coutts RT; McKenna KF; Baker GB
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):592-9. PubMed ID: 9840430
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4.
Fang J; Bourin M; Baker GB
Naunyn Schmiedebergs Arch Pharmacol; 1999 Feb; 359(2):147-51. PubMed ID: 10048600
[TBL] [Abstract][Full Text] [Related]
10. Fatalities associated with therapeutic use and overdose of atypical antipsychotics.
Trenton A; Currier G; Zwemer F
CNS Drugs; 2003; 17(5):307-24. PubMed ID: 12665390
[TBL] [Abstract][Full Text] [Related]
11. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.
Beunk L; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Guchelaar HJ; Houwink EJF; Risselada A; Rongen GAPJM; van Schaik RHN; Swen JJ; Touw D; van Westrhenen R; Deneer VHM; van der Weide J
Eur J Hum Genet; 2024 Mar; 32(3):278-285. PubMed ID: 37002327
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of post-clozapine antipsychotics: pharmacological implications.
Caccia S
Clin Pharmacokinet; 2000 May; 38(5):393-414. PubMed ID: 10843459
[TBL] [Abstract][Full Text] [Related]
13. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
15. CYP-mediated clozapine interactions: how predictable are they?
Chetty M; Murray M
Curr Drug Metab; 2007 May; 8(4):307-13. PubMed ID: 17504220
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
Walzer M; Bekersky I; Blum RA; Tolbert D
Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotic metabolism and excretion.
Sheehan JJ; Sliwa JK; Amatniek JC; Grinspan A; Canuso CM
Curr Drug Metab; 2010 Jul; 11(6):516-25. PubMed ID: 20540690
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 polymorphisms and response to antipsychotic therapy.
Scordo MG; Spina E
Pharmacogenomics; 2002 Mar; 3(2):201-18. PubMed ID: 11972442
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
20. The dosing of atypical antipsychotics.
de Leon J; Armstrong SC; Cozza KL
Psychosomatics; 2005; 46(3):262-73. PubMed ID: 15883149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
